HighTower Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.21M Sell
96,980
-28,338
-23% -$1.86M 0.01% 1136
2026
Q1
$8.92M Sell
125,318
-465,524
-79% -$36.7M 0.01% 936
2025
Q4
$48.5M Buy
590,842
+198,168
+50% +$15.4M 0.05% 365
2025
Q3
$29.5M Buy
392,674
+254,756
+185% +$19M 0.03% 486
2025
Q2
$10.2M Buy
137,918
+12
+0% +$835 0.01% 786
2025
Q1
$11.1M Sell
137,906
-3,968
-3% -$341K 0.02% 716
2024
Q4
$11.1M Sell
141,874
-199,796
-58% -$17M 0.02% 715
2024
Q3
$32.1M Buy
341,670
+97,050
+40% +$8.15M 0.05% 388
2024
Q2
$19.1M Buy
244,620
+15,416
+7% +$1.26M 0.03% 515
2024
Q1
$20.8M Sell
229,204
-4,533
-2% -$377K 0.03% 462
2023
Q4
$18M Sell
233,737
-24,510
-9% -$1.72M 0.03% 504
2023
Q3
$17.5M Buy
258,247
+8,224
+3% +$598K 0.03% 486
2023
Q2
$20.3M Sell
250,023
-13,702
-5% -$1.09M 0.04% 428
2023
Q1
$21.6M Buy
+263,725
New +$18.8M 0.05% 381

Other funds holding GEHC

HighTower Advisors's GEHC Position: Q2 2026 in Review

HighTower Advisors reduced its GE HealthCare (GEHC) stake by 23% in Q2 2026, selling an estimated $1.86M and leaving 96,980 shares worth $6.21M. The position accounts for 0.01% of the portfolio, ranked #1136.

HighTower Advisors first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $48.5M in Q4 2025. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • HighTower Advisors held 96,980 shares of GE HealthCare worth $6.21M as of Q2 2026.
  • HighTower Advisors sold 28,338 GE HealthCare shares in Q2 2026, an estimated $1.86M.
  • GE HealthCare made up 0.01% of HighTower Advisors's portfolio in Q2 2026, its #1136 holding.
  • HighTower Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • HighTower Advisors's GE HealthCare position peaked at $48.5M in Q4 2025.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.